The cellular process of autophagy (literally self-eating) is important during development and in the normal physiology of an organism. During autophagy, cellular components destined for degradation are enclosed in a double-membraned vesicle (the autophagosome), which then fuses with a lysosome where the contents are degraded and mostly recycled. Dysregulation of autophagy occurs in many diseases including cancer and neurodegeneration. Several recent papers contribute to our understanding of autophagy by identifying new molecular players in this process and new ways to manipulate autophagic pathways.
Adults Need Autophagy Too
Autophagy is thought to play a role in the tissue remodeling that occurs during fly metamorphosis. Now Juh asz et al. (2007) reveal that the Atg7 protein, a key regulator of autophagy, is dispensable for development but is important to keep neurodegeneration and the negative effects of stress at bay. The authors generated flies that lacked Atg7 and observed that starvation-induced autophagy in the larval fat body and developmental autophagy in the larval midgut were impaired in these flies. Despite these defects, these mutant flies were viable and remarkably made it through development with only a delay in the shrinking and elimination of the larval midgut, a normal process during development that is thought to require autophagy. Next, the authors evaluated the effects of Atg7 deficiency in adult flies. In response to both nutrient and oxidative stress, Atg7-deficient flies exhibited a reduced life span and a decrease in neuronal function with age. Further examination of the nervous system of these flies revealed an accumulation of ubiquitinated proteins and of inclusion bodies, extensive cell death of Atg7-deficient neurons, and progressive neurodegeneration. Thus, autophagy contributes to, but is not required for, cell death during fly development, whereas in adult flies, autophagy is important for preventing neuronal cell death in response to environmental stress and aging. How these opposing functions of autophagy are regulated is still an open question. G. Juh asz et al. (2007) . Genes Dev. 21, [3061] [3062] [3063] [3064] [3065] [3066] 
Autophagy Finds an ESCRT
In higher eukaryotes, autophagosomes fuse with endosomes to form ''amphisomes. '' Rusten et al. (2007) set out to determine whether factors involved in endosome biogenesis and function are involved in autophagy. Candidates include the ESCRT complex that is required for sorting of endosomes and Fab1/PIKfyve, which controls membrane homeostasis in late endosomes. The absence of ESCRT-I, II, or III in fly follicular epithelial cells or in the fat body of fly larvae caused the accumulation of autophagosomes but not amphisomes or autolysosomes even in the absence of starvation, a known inducer of autophagy. Additional experiments indicated that in the absence of ESCRT, fusion between the autophagosome and late endosomes or lysosomes is impaired. Interestingly, in the absence of Fab1, amphisomes accumulate indicating that Fab1 is important for maturation of amphisomes to autolysosomes. Recently, impaired ESCRT function has been associated with neurodegeneration. The authors found that reduced ESCRT function increased neurotoxicity in a fly model of Huntington's disease. Further work will elucidate this connection and also that between endosomal proteins and autophagy. T.E. Rusten et al. (2007) . Curr. Biol. 17, 1817 -1825 . Published online October 11, 2007 . 10.1016 /j.cub.2007 .032.
Taking Control of Autophagy
As discussed above, impaired autophagy has many negative consequences, particularly the degeneration of neurons. Therefore, manipulating autophagic pathways could be useful therapeutically. To this end, Zhang et al. (2007) devised a screen using high-throughput imaging to identify small molecule regulators of autophagy. The authors expressed a fluorescent marker of autophagosome formation in a human glioblastoma cell line to monitor the induction of autophagy. These cells were grown in 96 well plates and treated with 480 compounds from a known library of bioactive compounds. Approximately 70 compounds caused a >50% increase in fluorescence levels indicative of the induction of autophagy, including several compounds known to increase autophagosome formation. The authors then focused on 47 compounds that did not affect cell viability. To ensure that these 47 compounds were really targeting autophagic degradation, they monitored the degradation of long-lived proteins that are known to be degraded through the autophagic pathway. This narrowed the list down to 8 compounds that increased the degradation rate of long-lived proteins. Several of these compounds are FDA-approved drugs, including the antipsychotics fluspirilene, trifluoperazine, and pimozid. Treating cells expressing polyglutamine proteins (to induce accumulation of misfolded proteins) with these compounds revealed that 7 of the 8 molecules were able to reduce the amount of misfolded protein probably by stimulating autophagic degradation. The authors determined that the target of these compounds is not mTOR, a known inhibitor of autophagy; the cellular targets of these compounds await further investigation. Inducing autophagy could be a useful therapeutic strategy as the accumulation of misfolded proteins due to impaired autophagy has been associated with many diseases. L. Zhang et al. (2007) . Proc. Natl. Acad. Sci. USA 104, 19023-19028. Published online November 16, 2007 . 10.1073 .
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Drosophila cells mutant for fab1 accumulate autophagic material (green), whereas wild-type neighboring cells (red) do not. Image courtesy of H. Stenmark.
